Koshinski Asset Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-6,874
| Closed | -$202K | – | 618 |
|
|
2022
Q3 | $202K | Sell |
6,874
-244
| -3% | -$9.25K | 0.02% | 497 |
|
|
2022
Q2 | $387K | Sell |
7,118
-136
| -2% | -$7.51K | 0.04% | 418 |
|
|
2022
Q1 | $395K | Buy |
7,254
+83
| +1% | +$4.51K | 0.03% | 428 |
|
|
2021
Q4 | $395K | Buy |
7,171
+96
| +1% | +$4.99K | 0.03% | 447 |
|
|
2021
Q3 | $338K | Buy |
7,075
+2,343
| +50% | +$118K | 0.03% | 479 |
|
|
2021
Q2 | $236K | Sell |
4,732
-1,939
| -29% | -$93.2K | 0.03% | 496 |
|
|
2021
Q1 | $298K | Buy |
6,671
+989
| +17% | +$44.9K | 0.03% | 477 |
|
|
2020
Q4 | $261K | Sell |
5,682
-2,369
| -29% | -$109K | 0.03% | 464 |
|
|
2020
Q3 | $378 | Buy |
8,051
+61
| +0.8% | +$3.06K | 0.05% | 352 |
|
|
2020
Q2 | $407K | Buy |
7,990
+653
| +9% | +$33.5K | 0.07% | 317 |
|
|
2020
Q1 | $347K | Buy |
7,337
+9
| +0.1% | +$480 | 0.07% | 315 |
|
|
2019
Q4 | $431K | Buy |
+7,328
| New | +$408K | 0.07% | 335 |
|
|
2019
Q2 | – | Sell |
-4,267
| Closed | -$223 | – | 303 |
|
|
2019
Q1 | $223 | Sell |
4,267
-3,911
| -48% | -$195K | 0.06% | 343 |
|
|
2018
Q4 | $391K | Sell |
8,178
-4,888
| -37% | -$241K | 0.1% | 257 |
|
|
2018
Q3 | $656K | Buy |
13,066
+7,908
| +153% | +$402K | 0.09% | 280 |
|
|
2018
Q2 | $260K | Sell |
5,158
-634
| -11% | -$31.9K | 0.08% | 313 |
|
|
2018
Q1 | $283K | Sell |
5,792
-1,182
| -17% | -$55K | 0.09% | 293 |
|
|
2017
Q4 | $309K | Sell |
6,974
-606
| -8% | -$28K | 0.08% | 330 |
|
|
2017
Q3 | $385K | Buy |
7,580
+92
| +1% | +$4.67K | 0.13% | 243 |
|
|
2017
Q2 | $404K | Sell |
7,488
-521
| -7% | -$27.8K | 0.15% | 220 |
|
|
2017
Q1 | $422K | Buy |
8,009
+422
| +6% | +$21.4K | 0.17% | 184 |
|
|
2016
Q4 | $365K | Buy |
7,587
+509
| +7% | +$25.1K | 0.18% | 186 |
|
|
2016
Q3 | $382K | Buy |
7,078
+5
| +0.1% | +$274 | 0.19% | 168 |
|
|
2016
Q2 | $383K | Buy |
7,073
+218
| +3% | +$11.5K | 0.21% | 157 |
|
|
2016
Q1 | $596K | Buy |
6,855
+692
| +11% | +$34.5K | 0.38% | 92 |
|
|
2015
Q4 | $311K | Sell |
6,163
-55
| -0.9% | -$2.8K | 0.22% | 140 |
|
|
2015
Q3 | $324K | Buy |
6,218
+697
| +13% | +$36.3K | 0.21% | 150 |
|
|
2015
Q2 | $287K | Sell |
5,521
-536
| -9% | -$30.2K | 0.18% | 162 |
|
|
2015
Q1 | $349K | Buy |
6,057
+91
| +2% | +$5.22K | 0.23% | 134 |
|
|
2014
Q4 | $319K | Buy |
+5,966
| New | +$334K | 0.18% | 151 |
|
Other funds holding GSK
JEST
AWA
Koshinski Asset Management's GSK Position: Q4 2022 in Review
Koshinski Asset Management sold out of GSK (GSK) in Q4 2022, closing a stake of 6,874 shares — an estimated $202K sold.
Koshinski Asset Management first reported a position in GSK in Q4 2014 and held it in 30 quarters. The position peaked at $656K in Q3 2018. 813 funds tracked by Wall St. Rank hold GSK as of Q4 2022.
- Koshinski Asset Management reported no remaining GSK position as of Q4 2022 after selling out during the quarter.
- Koshinski Asset Management sold 6,874 GSK shares in Q4 2022, an estimated $202K.
- Koshinski Asset Management first reported a position in GSK in Q4 2014 and held it in 30 quarters.
- Koshinski Asset Management's GSK position peaked at $656K in Q3 2018.
- 813 funds tracked by Wall St. Rank held GSK as of Q4 2022.
Based on Koshinski Asset Management's 13F filing for Q4 2022, filed 24 Jan 2023.